Teva Pharmaceuticals Europe B.V.
GPTKB entity
Properties (107)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
Cephalon
Actavis Generics Allergan's generics business |
gptkbp:awards |
Innovation Award 2020
Sustainability Award 2019 Best Employer Award 2021 Pharma_Company_of_the_Year_2020 Best_Workplace_in_Europe_2021 |
gptkbp:corporateSocialResponsibility |
Community engagement
Sustainability initiatives Employee well-being Access to medicines |
gptkbp:employs |
thousands of employees
|
gptkbp:focus |
Multiple sclerosis
Oncology Pain management Autoimmune diseases Neurology Respiratory |
gptkbp:focusesOn |
neurology
oncology pain management respiratory diseases |
gptkbp:founded |
1901
|
gptkbp:foundedIn |
1901
|
gptkbp:founder |
Salomon_Steinberg
|
gptkbp:hasProductLine |
gptkb:Metformin
gptkb:Simvastatin Lisinopril Fexofenadine Ciprofloxacin Levothyroxine Duloxetine Breztri Aerosphere Diphenhydramine Budesonide Fluticasone Mometasone Procrit Aripiprazole Bupropion Escitalopram Quetiapine Risperidone Sertraline Venlafaxine Ipratropium Ajovy Atorvastatin Omeprazole Copaxone Clonazepam Gabapentin Montelukast Alprazolam Buspirone Diazepam Hydroxyzine Lorazepam Promethazine Austedo Beclomethasone Cetirizine Ciclesonide Fentanyl Transdermal System Formoterol Levocetirizine Qvar Theophylline Tiotropium Trisenox Vantrela ER Zecuity Salmeterol Zafirlukast |
gptkbp:hasSubsidiary |
gptkb:Teva_UK_Limited
Teva_France_S.A.S. Teva_Germany_GmbH Teva_Italy_S.r.l. Teva_Spain_S.L. |
gptkbp:headquarteredIn |
gptkb:Amsterdam
|
gptkbp:headquarters |
Amsterdam,_Netherlands
|
https://www.w3.org/2000/01/rdf-schema#label |
Teva Pharmaceuticals Europe B.V.
|
gptkbp:industry |
Pharmaceuticals
|
gptkbp:numberOfEmployees |
Approximately 40,000
|
gptkbp:offers |
generic drugs
specialty medicines |
gptkbp:operatesIn |
Europe
|
gptkbp:parentCompany |
gptkb:Teva_Pharmaceutical_Industries_Ltd.
|
gptkbp:partnerships |
Partnership with Pfizer
Partnership with Sanofi Partnership with Takeda Partnership with Merck Partnership_with_Procter_&_Gamble |
gptkbp:products |
Specialty medicines
Generic_drugs |
gptkbp:researchAndDevelopment |
Focus on complex generics
Focus on biosimilars Focus on innovative medicines |
gptkbp:revenue |
$16.7 billion (2020)
|
gptkbp:subsidiary |
gptkb:Teva_UK_Limited
Teva Italia S.r.l. Teva_France_S.A.S. Teva_Germany_GmbH Teva_Spain_S.L. |
gptkbp:website |
www.tevapharm.com
|